Charles River Laboratories International, Inc.CRLNYSE
Loading
Debt to Equity Over TimeNormalizing
Percentile Rank14
3Y CAGR-2.4%
5Y CAGR-1.1%
Year-over-Year Change
Debt-to-equity ratio
3Y CAGR
-2.4%/yr
vs -5.2%/yr prior
5Y CAGR
-1.1%/yr
Consistent
Acceleration
+2.8pp
Accelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
1 yr
Consecutive growthNormalizing
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.97 | +23.1% |
| 2024 | 0.79 | -7.7% |
| 2023 | 0.85 | -18.1% |
| 2022 | 1.04 | -17.7% |
| 2021 | 1.26 | +23.8% |
| 2020 | 1.02 | -17.5% |
| 2019 | 1.24 | -3.9% |
| 2018 | 1.29 | +17.6% |
| 2017 | 1.10 | -25.8% |
| 2016 | 1.48 | - |